• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠疫情相关出版物的洪流:一则警示

The Flood of COVID-19 Publications: a Word of Caution.

作者信息

Tiwari Punit, Kaur Harmeet

机构信息

Department of Orthopaedics, Maharishi Markandeshwar Medical College and Hospital, Kumarhatti, Solan, Himachal Pradesh India.

Department of Radiodiagnosis, All India Institute of Medical Sciences, Bathinda, Punjab India.

出版信息

SN Compr Clin Med. 2020;2(12):2511-2513. doi: 10.1007/s42399-020-00656-8. Epub 2020 Nov 27.

DOI:10.1007/s42399-020-00656-8
PMID:33263102
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7694586/
Abstract

The entire world is currently experiencing difficult times with respect to physical, mental, and socio-economic health. The rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) since early 2020 caught the world by surprise. While there are promising developments, to date, there is no available drug or vaccine, and researchers are working around the clock to develop a solution. Sadly, all these crucial efforts are being affected and, at times, misguided and derailed by the publication of fake articles by so-called researchers and perhaps the mismanagement by authentic and predatory journals. The problem is that genuine and good quality articles are getting lost in the crowd. More than ever, it is now the time to bring in stricter controls and to follow due diligence before allowing articles into the public domain. At the same time, it has become life-saving to separate the wheat from the chaff so that the genuine studies of first-hand experience of handling and management of COVID-19 patients, and authentic research is not submerged in this flood of unreliable publications.

摘要

目前,整个世界在身体、心理和社会经济健康方面都正经历着艰难时期。自2020年初以来,严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的迅速传播让全世界措手不及。虽然有一些令人鼓舞的进展,但迄今为止,尚无可用的药物或疫苗,研究人员正在夜以继日地努力寻找解决方案。可悲的是,所有这些关键努力都受到了影响,有时还被所谓研究人员发表的虚假文章误导和偏离了方向,或许也受到了正规期刊和掠夺性期刊管理不善的影响。问题在于,真正高质量的文章在众多文章中被淹没了。现在比以往任何时候都更需要加强更严格的管控,并在文章进入公共领域之前进行尽职调查。与此同时,去伪存真变得至关重要,这样一来,关于COVID-19患者处理和管理的第一手经验的真实研究以及可靠的研究才不会被大量不可靠的出版物所淹没。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/794d/7694586/654da9d136d9/42399_2020_656_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/794d/7694586/654da9d136d9/42399_2020_656_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/794d/7694586/654da9d136d9/42399_2020_656_Fig1_HTML.jpg

相似文献

1
The Flood of COVID-19 Publications: a Word of Caution.新冠疫情相关出版物的洪流:一则警示
SN Compr Clin Med. 2020;2(12):2511-2513. doi: 10.1007/s42399-020-00656-8. Epub 2020 Nov 27.
2
Publishing in pandemic times: A bibliometric analysis of early medical publications on Kawasaki-like disease (MIS-C, PIMS-TS) related to SARS-CoV-2.大流行时期的出版:与 SARS-CoV-2 相关的川崎病样疾病(MIS-C、PIMS-TS)早期医学出版物的文献计量分析。
Arch Pediatr. 2021 Aug;28(6):464-469. doi: 10.1016/j.arcped.2021.05.002. Epub 2021 May 28.
3
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.新冠病毒-19(Sars-Cov-2)的英国变体不应造成疫苗问题。
J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):1-4. doi: 10.23812/21-3-E.
4
Emergence, evolution, and vaccine production approaches of SARS-CoV-2 virus: Benefits of getting vaccinated and common questions.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒的出现、演变及疫苗生产方法:接种疫苗的益处及常见问题
Saudi J Biol Sci. 2022 Apr;29(4):1981-1997. doi: 10.1016/j.sjbs.2021.12.020. Epub 2021 Dec 13.
5
A Review of COVID-19-Related Publications and Lag Times During the First Six Months of the Year 2020.2020 年上半年 COVID-19 相关文献及滞后时间综述。
West J Emerg Med. 2021 Jun 29;22(4):958-962. doi: 10.5811/westjem.2021.3.51737.
6
Role of biological Data Mining and Machine Learning Techniques in Detecting and Diagnosing the Novel Coronavirus (COVID-19): A Systematic Review.生物数据挖掘和机器学习技术在检测和诊断新型冠状病毒 (COVID-19) 中的作用:系统评价。
J Med Syst. 2020 May 25;44(7):122. doi: 10.1007/s10916-020-01582-x.
7
Scientific basis of the OCRA method for risk assessment of biomechanical overload of upper limb, as preferred method in ISO standards on biomechanical risk factors.OCRA 方法评估上肢生物力学过载风险的科学基础,作为 ISO 生物力学风险因素标准中的首选方法。
Scand J Work Environ Health. 2018 Jul 1;44(4):436-438. doi: 10.5271/sjweh.3746.
8
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
9
COVID-19 Publications in Family Medicine Journals in 2020: A PubMed-Based Bibliometric Analysis.2020 年家庭医学期刊中关于 COVID-19 的出版物:基于 PubMed 的文献计量分析。
Int J Environ Res Public Health. 2021 Jul 21;18(15):7748. doi: 10.3390/ijerph18157748.
10
Pathogenesis-directed therapy of 2019 novel coronavirus disease.针对 2019 新型冠状病毒病的发病机制导向治疗。
J Med Virol. 2021 Mar;93(3):1320-1342. doi: 10.1002/jmv.26610. Epub 2020 Nov 10.

本文引用的文献

1
The "Pandemic" of Disinformation in COVID-19.新冠疫情中的虚假信息“大流行”。
SN Compr Clin Med. 2020;2(9):1287-1289. doi: 10.1007/s42399-020-00439-1. Epub 2020 Aug 1.
2
Retraction-Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis.撤稿——羟氯喹或氯喹联合或不联合大环内酯类药物治疗新型冠状病毒肺炎:一项多国注册研究分析
Lancet. 2020 Jun 13;395(10240):1820. doi: 10.1016/S0140-6736(20)31324-6. Epub 2020 Jun 5.
3
Retraction: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med. DOI: 10.1056/NEJMoa2007621.
撤稿声明:2019年冠状病毒病中的心血管疾病、药物治疗和死亡率。《新英格兰医学杂志》。DOI:10.1056/NEJMoa2007621
N Engl J Med. 2020 Jun 25;382(26):2582. doi: 10.1056/NEJMc2021225. Epub 2020 Jun 4.
4
Hydroxychloroquine for the Prevention of Covid-19 - Searching for Evidence.羟氯喹预防新型冠状病毒肺炎——寻找证据
N Engl J Med. 2020 Aug 6;383(6):585-586. doi: 10.1056/NEJMe2020388. Epub 2020 Jun 3.
5
An Update on Current Therapeutic Drugs Treating COVID-19.治疗新型冠状病毒肺炎的当前治疗药物最新情况
Curr Pharmacol Rep. 2020;6(3):56-70. doi: 10.1007/s40495-020-00216-7. Epub 2020 May 11.
6
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro.美国食品药品监督管理局批准的药物伊维菌素可抑制 SARS-CoV-2 的体外复制。
Antiviral Res. 2020 Jun;178:104787. doi: 10.1016/j.antiviral.2020.104787. Epub 2020 Apr 3.
7
Covid-19 - The Search for Effective Therapy.新冠病毒-19:寻找有效疗法
N Engl J Med. 2020 May 7;382(19):1851-1852. doi: 10.1056/NEJMe2005477. Epub 2020 Mar 18.
8
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
9
Predatory Journals: Harmful to Patients, the Public, and the Integrity of Scientific Research.掠夺性期刊:对患者、公众及科学研究诚信有害。
Skinmed. 2017 Jun 1;15(3):167-168. eCollection 2017.
10
Dangerous Predatory Publishers Threaten Medical Research.危险的掠夺性出版商威胁医学研究。
J Korean Med Sci. 2016 Oct;31(10):1511-3. doi: 10.3346/jkms.2016.31.10.1511.